Sargent Investment Group, LLC Palisade Bio, Inc. Transaction History

Sargent Investment Group, LLC

  • $546 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 26, 2022
BUY
$0.11 - $83.85 $47,300 - $36.1 Million
430,000 Added 179.17%
670,000 $76,000
Q2 2022

Jul 26, 2022
BUY
$0.41 - $1.04 $45,100 - $114,400
110,000 Added 84.62%
240,000 $98,000
Q4 2021

Feb 11, 2022
BUY
$1.3 - $2.96 $32,500 - $74,000
25,000 Added 23.81%
130,000 $169,000
Q3 2021

Nov 12, 2021
BUY
$2.35 - $3.93 $246,750 - $412,650
105,000 New
105,000 $278,000

About PALISADE BIO, INC.

PALI Quotes by TradingView
  • Ticker PALI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,240,200
  • Market Cap $122M
  • Description
  • Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal tract. Its lead therapeutic candidate is LB1148, an oral liquid formulation of the digestive enzym...
More about PALI
Track This Portfolio

Track Sargent Investment Group, LLC Portfolio

Follow Sargent Investment Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sargent Investment Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sargent Investment Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email